Fosun International gets Awards from Corporate Governance Asia
The magazine Corporate Governance Asia presented the 12th Asian Excellence Award on January 11th, 2023. Asia’s Best CEO awards were given to Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International Limited (also known as “Fosun International,. Fosun International has received prizes for Best Corporate Communications and Best CSR in Asia.
Corporate Responsibility Asia is one of the Asian-Pacific region’s top publications on corporate governance. For organisations that have excelled in financial performance, corporate governance, corporate social responsibility, environmental protection, corporate communication, and investor relations, it gives the Asian Excellence Award. The 12th Asian Excellence Award’s subject for this year is “Leadership: Reigniting Asia.” The awards are intended to honour business leaders who have shown a strong commitment to social responsibility during the pandemic, organisations that have generously contributed to the fight against the pandemic, teams that have actively shared positive ESG stories, and organisations that have actively promoted global sustainable development.
The COVID-19 pandemic, which has been sweeping the globe for three years, has reportedly presented enormous issues for businesses all around the world, according to Corporate Governance Asia. However, a lot of businesses responded actively to the pandemic’s challenges and demonstrated strong resilience and adaptability throughout it. As a result, all of their business, financial, and operational indicators have shown a steady recovery trend. Some businesses have shown a great sense of social duty and mission by completely supporting the fight against the epidemic and navigating the challenges alongside the rest of society.
“We are extremely honoured to earn numerous honours from Corporate Governance Asia, including Asia’s Best CEO and Asia’s Best CSR,” stated Chen Qiyu, Executive Director and Co-CEO of Fosun International. The awards, which honour the Group’s efforts, are given to the entire Fosun team as well as to specific winners. Fosun has always been a proponent of doing the right thing, even when it’s challenging or takes time to grow. The COVID-19 mRNA vaccine (COMIRNATY®), which we co-developed with the German biotechnology company BioNTech at the start of the pandemic, was a key component in the pandemic’s successful eradication. In addition, Azvudine, the first locally produced small molecule oral drug for HIV, has been developed and exclusively marketed by Fosun Pharma and Genuine Biotech.
In order to better meet the demands for COVID-19 patient home treatment, Fosun Pharma recently reached out to a number of online medical platforms for cooperation. The goal is to improve Azvudine’s accessibility through multiple channels. Azvudine has been distributed to 31 provinces, municipalities, and autonomous entities nationwide since August 2022. Azvudine, a COVID medication, would be donated in phases to 180 counties in the central and western rural areas of China for RMB100 million, according to a 9 January 2023 announcement by the Fosun Foundation, Fosun Pharma, and Genuine Biotech.